Excellent research, ongoing internationalization, deregulation and new business opportunities, especially in regenerative medicine, make Japan a promising market and a frontrunner of the world’s fastest growing region, Asia. BioJapan 2016 in Yokohama will be attended by nearly all Japanese and many international Pharma companies, a large number of Biotechs as well as universities and research organisations.